for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Accelerate Diagnostics Inc

AXDX.OQ

現在値

16.54USD

変化

-0.05(-0.30%)

出来高

1,553

本日のレンジ

16.54

 - 

16.54

52週レンジ

4.61

 - 

22.09

∙ 約20分前の相場を表示しています。

適時開示

Accelerate Diagnostics Q1 Loss Per Share $0.39

May 7 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES COVID-19 BUSINESS UPDATES.Q1 LOSS PER SHARE $0.39.Q1 SALES $2.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $2.3 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.39 -- REFINITIV IBES DATA.

Accelerate Diagnostics Withdraws 2020 Annual Financial Guidance, Reports Prelim Q1 Financial Results

April 15 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS ANNOUNCES PRELIMINARY FIRST QUARTER FINANCIAL RESULTS AND PROVIDES COVID-19 BUSINESS UPDATES; SCHEDULES FIRST QUARTER 2020 FINANCIAL RESULTS CONFERENCE CALL FOR MAY 7, 2020.SEES Q1 2020 SALES $2.3 MILLION.IS WITHDRAWING 2020 ANNUAL FINANCIAL GUIDANCE IT PROVIDED ON JANUARY 15, 2020.ENDED QUARTER WITH TOTAL CASH, INVESTMENTS, AND CASH EQUIVALENTS OF $92.0 MILLION.

Accelerate Diagnostics Reports Q4 Loss Per Share $0.39

Feb 27 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS REPORTS FOURTH QUARTER 2019 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.39.Q4 SALES ROSE 94 PERCENT TO $3.5 MILLION.Q4 REVENUE ESTIMATE $4.7 MILLION -- REFINITIV IBES DATA.Q4 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES DATA.

Accelerate Diagnostics Says Lawrence Mehren To Retire As CEO

Dec 4 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS ANNOUNCES EXECUTIVE TRANSITION: LAWRENCE MEHREN TO RETIRE AS CHIEF EXECUTIVE OFFICER; JACK PHILLIPS APPOINTED AS SUCCESSOR.ACCELERATE DIAGNOSTICS INC - MEHREN WILL SUPPORT TRANSITION PROCESS, REMAINING AS A KEY ADVISOR TO COMPANY THROUGH 2021.ACCELERATE DIAGNOSTICS INC - JACK PHILLIPS, COMPANY'S CHIEF OPERATING OFFICER, APPOINTED AS CHIEF EXECUTIVE OFFICER EFFECTIVE FEBRUARY 1, 2020.

Accelerate Diagnostics Reports Q3 Loss Per Share Of $0.37

Nov 7 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS REPORTS THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.37.Q3 SALES $2.3 MILLION VERSUS $1.4 MILLION.Q3 REVENUE ESTIMATE $3.1 MILLION -- REFINITIV IBES DATA.Q3 EARNINGS PER SHARE ESTIMATE $-0.38 -- REFINITIV IBES DATA.

Accelerate Diagnostics says On Aug 20, Co And Entity Affiliated With Phillips Entered Into Securities Purchase Agreement

Aug 21 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS INC - ON AUG 20, CO AND ENTITY AFFILIATED WITH PHILLIPS ENTERED INTO SECURITIES PURCHASE AGREEMENT.ACCELERATE DIAGNOSTICS INC - PURCHASE AGREEMENT FOR ISSUANCE, SALE BY CO OF AGGREGATE OF 55,586 SHARES OF CO'S COMMON STOCK IN OFFERING.ACCELERATE DIAGNOSTICS - SHARES WERE SOLD AT PURCHASE PRICE OF $17.99 PER SHARE.

Accelerate Diagnostics Reports Q2 Loss Per Share $0.38

Aug 8 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.38.Q2 SALES $1.8 MILLION VERSUS $1.7 MILLION.Q2 REVENUE ESTIMATE $2.5 MILLION -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE ESTIMATE $-0.39 -- REFINITIV IBES DATA.ACCELERATE DIAGNOSTICS - ACHIEVED MIXED RESULTS IN Q2, AS REVENUE, PLACEMENTS WERE LIGHTER THAN EXPECTED DUE TO LOWER-THAN-EXPECTED CAPITAL SALES IN EMEA.

Accelerate Diagnostics Q1 Loss Per Share $0.40

May 9 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.40.Q1 SALES $1.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $2.1 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES DATA.

Accelerate Diagnostics Q4 Loss Per Share $0.41

Feb 19 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS REPORTS 2018 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.41.Q4 SALES $1.8 MILLION VERSUS $2.1 MILLION.Q4 REVENUE ESTIMATE $2.6 MILLION -- REFINITIV IBES DATA.Q4 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES DATA.

Accelerate Diagnostics Sees Q4 Revenue About $1.8 Mln

Jan 6 (Reuters) - Accelerate Diagnostics Inc <AXDX.O>::ACCELERATE DIAGNOSTICS ANNOUNCES PRELIMINARY 2018 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS.SEES Q4 REVENUE ABOUT $1.8 MILLION.SEES FY 2018 REVENUE $5.7 MILLION.ACCELERATE DIAGNOSTICS - NET CASH USED, EXCLUDING FINANCING, IS EXPECTED TO BE APPROXIMATELY $14.1 MILLION FOR Q4 AND $64.1 MILLION FOR FULL-YEAR 2018.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up